New magnetic resonance techniques for acute ischemic stroke.

Neuroimaging was revolutionized by the development of computed tomography (CT) and standard T1- and T2-weighted magnetic resonance imaging (MRI). Magnetic resonance imaging and CT can adequately distinguish hemorrhage from infarction and depict ischemic stroke 12 to 24 hours after onset. However, during the critical initial hours after the onset of ischemic stroke, these imaging technologies do not adequately demonstrate the location and extent of infarction. Diffusion-weighted MRI and perfusion imaging, as well as advances in magnetic resonance spectroscopy, will enhance our ability to evaluate ischemic stroke shortly after onset. Some of the uses of MRI techniques are as follows: (1) Diffusion-weighted imaging can depict the location and extent of the ischemic lesion as soon as a stroke patient is available for examination. (2) Perfusion imaging evaluates blood flow within the brain's microvasculature and can reveal regions of perfusion deficits corresponding to major vascular territories. (3) Magnetic resonance spectroscopy evaluates metabolic abnormalities associated with focal brain ischemia by specific biochemical measurements. These MRI techniques will rapidly provide important information to clinicians about ischemia, guiding diagnosis and helping in the development of acute stroke interventions to improve outcome.

[1]  R R Edelman,et al.  Clinical Outcome in Ischemic Stroke Predicted by Early Diffusion-Weighted and Perfusion Magnetic Resonance Imaging: A Preliminary Analysis , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  David G. Norris,et al.  Evolution of Regional Changes in Apparent Diffusion Coefficient during Focal Ischemia of Rat Brain: The Relationship of Quantitative Diffusion NMR Imaging to Reduction in Cerebral Blood Flow and Metabolic Disturbances , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  W. Yuh,et al.  Magnetic resonance versus computed tomographic imaging in acute stroke. , 1995, Stroke.

[4]  A. Blamire,et al.  Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. , 1995, Stroke.

[5]  B. Siewert,et al.  Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.

[6]  B. Dardzinski,et al.  Multislice diffusion mapping for 3-D evolution of cerebral ischemia in a rat stroke model , 1995, Neurology.

[7]  R R Edelman,et al.  Echo-planar MR imaging. , 1994, Radiology.

[8]  B J Soher,et al.  Acute stroke: evaluation with serial proton MR spectroscopic imaging. , 1994, Radiology.

[9]  A. Nobre,et al.  Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. , 1994, Radiology.

[10]  B. Dardzinski,et al.  MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia , 1994, Neurology.

[11]  K. Hossmann,et al.  Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites. , 1994, Stroke.

[12]  L Bolinger,et al.  Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Blamire,et al.  Early Temporal Variation of Cerebral Metabolites After Human Stroke: A Proton Magnetic Resonance Spectroscopy Study , 1993, Stroke.

[14]  R. Ordidge,et al.  Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia , 1993, Neurology.

[15]  C. Sotak,et al.  Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion‐weighted MRI , 1993, Neurology.

[16]  J A Helpern,et al.  Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. , 1992, Radiology.

[17]  M. Weiner,et al.  Elevated Lactate and Alkalosis in Chronic Human Brain Infarction Observed by 1H and 31P MR Spectroscopic Imaging , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  R. Turner,et al.  Diffusion MR imaging: clinical applications. , 1992, AJR. American journal of roentgenology.

[19]  C. Sotak,et al.  New magnetic resonance techniques for evaluating cerebrovascular disease , 1992, Annals of neurology.

[20]  A. Blamire,et al.  Spectroscopic imaging of stroke in humans , 1992, Neurology.

[21]  R G Shulman,et al.  Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients , 1992, Stroke.

[22]  Wei Li,et al.  Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. , 1992, Radiology.

[23]  Y Tamagawa,et al.  Adult and neonatal human brain: diffusional anisotropy and myelination with diffusion-weighted MR imaging. , 1991, Radiology.

[24]  J W Belliveau,et al.  Functional cerebral imaging by susceptibility‐contrast NMR , 1990, Magnetic resonance in medicine.

[25]  M E Moseley,et al.  Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. , 1990, Acta neurochirurgica. Supplementum.

[26]  J. Frahm,et al.  Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.

[27]  P. V. van Rijen,et al.  Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. , 1988, Stroke.

[28]  B. Drayer,et al.  Chronic adult cerebral infarction studied by phosphorus NMR spectroscopy. , 1986, Radiology.

[29]  Shopfner Ce,et al.  Genu varus and valgus in children. , 1969 .